Patients with a history of pancreatitis, medullary thyroid cancer, or serious gastrointestinal disorders should assess the risks versus benefits with their provider
Just be sure to consult your healthcare provider about your options, and always follow their directions exactly when taking either or both of these drugs for obesity management
However, any pronounced colour change, particularly to red, pink, brown, or any other unexpected hue, falls outside the normal specification and requires immediate attention
"Offering Zepbound single-dose vialsthe most affordable branded incretin medicine by list pricethrough another platform to LillyDirect will help ensure broader availability of rigorously tested, FDA-approved and regulated obesity treatment," said Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA in a statement
Patients experiencing significant gastrointestinal side effects may benefit from temporary dose reduction or slowing the titration schedule
Persistent symptoms may indicate antibiotic resistance, an alternative diagnosis, or a complicated infection that requires different treatment